Population-based cohort study of Toxoplasma gondii P22 antibody positivity correlation with anxiety
Journal of Affective Disorders · 2024-08 · 359 · 41-48
DOI: 10.1016/j.jad.2024.05.043 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Affective Disorders, 2024-08. Verfasst von Lili Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Diseases Research, School of Public Health, Key Laboratory of Infecti…. Hauptthemen laut MEDLINE: Toxoplasma, Toxoplasmosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Accumulating evidence suggests that latent infection with Toxoplasma gondii (T. gondii) is associated with a variety of neuropsychiatric and behavioral conditions. This research aims to explore the potential correlation between T. gondii antibody positivity and neuropsychiatric disorders through a comprehensive prospective cohort study. METHODS: The cohort study utilized the UK Biobank database to recruit 8814 individuals with no prior diagnosis of neuropsychiatric disorders. Cox proportional hazards models were employed to investigate the associations between T. gondii P22 antibody seropositivity (P22+) and the development of various types of neuropsychiatric disorders. RESULTS: Of the population, 14.65 % tested positive for T. gondii P22 antibody. The presence of T. gondii P22 antibody showed a slight inverse association with epilepsy (HR: 0.28; 95 % CI: 0.10-0.77), while it was positively associated with an increased risk of developing anxiety disorders (HR: 1.38; 95 % CI: 1.04-1.83). LIMITATIONS: The study sample consisted mostly of white British individuals aged 40 to 69 years old. Although we adjusted for potential confounders, there may be other unmeasured and residual confounding factors that could have influenced our reported associations. CONCLUSIONS: The findings suggested an increased risk of anxiety and potential evidence of epilepsy associated with T. gondii P22+. However, our analysis did not reveal an increased risk of several other neuropsychiatric conditions including Alzheimer's disease, dementia, substance abuse disorders, depression, and neurodegenerative disorders, associated with P22 antibody seropositivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Diseases Research, School of Public Health, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Southern…
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Yang, L., Wang, B., Wu, S., Yang, Z., Xin, Z., Zheng, S., Zou, W., Zhang, C., Chen, J., & Peng, H. (2024). Population-based cohort study of Toxoplasma gondii P22 antibody positivity correlation with anxiety. Journal of Affective Disorders, 359, 41-48. https://doi.org/10.1016/j.jad.2024.05.043
Vancouver
Yang L, Wang B, Wu S, Yang Z, Xin Z, Zheng S, et al. Population-based cohort study of Toxoplasma gondii P22 antibody positivity correlation with anxiety. Journal of Affective Disorders. 2024;359:41-48. doi:10.1016/j.jad.2024.05.043
BibTeX
@article{Yang2024,
author = {Yang, Lili and Wang, Biyun and Wu, Shuizhen and Yang, Zihan and Xin, Zixuan and Zheng, Shuyu and Zou, Weihao and Zhang, Chi and Chen, Jiating and Peng, Hongjuan},
title = {Population-based cohort study of Toxoplasma gondii P22 antibody positivity correlation with anxiety},
journal = {Journal of Affective Disorders},
year = {2024},
volume = {359},
pages = {41--48},
doi = {10.1016/j.jad.2024.05.043}
}
EUVIMED